bpc-157 human clinical trials randomized controlled trial Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation | Journal of Molecular Medicine The Hidden Risks of BPC‑157:

Tesamorelin Goal: Reduce visceral (deep belly) fat A clinically proven GHRH analogue shown to meaningfully reduce visceral adipose tissue, improve lipid profiles, and support metabolic healthall while preserving lean muscle

First, we used the consistent failure of spontaneous healing of transected rat sciatic nerve in anastomosed nerve [79]

The injection itself is usually hydroxocobalamin, which the UK prefers over cyanocobalamin because it stays in the body longer, as set out in the BNF entry

10.1016/sasj-2007-0113-rr 79 TschuggA.DiepersM.SimoneS.MichnacsF.QuirbachS.StrowitzkiM.et al (2017)

Cerebellar premotor output neurons collateralize to innervate the cerebellar cortex